Nuvectis Pharma, Inc. (NASDAQ:NVCT) showed up in the 13F filings of 47 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 764,441 | -18,364 | -2.35% | $5,909,128.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 659,879 | 659,879 | 0.00% | $5,100,865.00 |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 31 Mar, 2026 | 651,757 | 65,437 | 11.16% | $5,038,082.00 |
| Occam Crest Management LP | 31 Mar, 2026 | 407,147 | 27,147 | 7.14% | $3,147,246.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 384,105 | 20,081 | 5.52% | $2,969,729.00 |
| BALDWIN WEALTH PARTNERS LLC/MA | 31 Mar, 2026 | 378,625 | -11,000 | -2.82% | $2,926,771.00 |
| State Street Corp | 31 Mar, 2026 | 166,516 | 11,850 | 7.66% | $1,287,169.00 |
| Northern Trust Corp | 31 Mar, 2026 | 124,212 | 7,807 | 6.71% | $960,159.00 |
| VANGUARD FIDUCIARY TRUST CO | 31 Mar, 2026 | 114,842 | 114,842 | 0.00% | $887,729.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 31 Mar, 2026 | 105,286 | -28,868 | -21.52% | $813,861.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 92,154 | 92,154 | 0.00% | $712,350.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 78,425 | 78,425 | 0.00% | $606,225.00 |
| OPPENHEIMER & CO INC | 31 Mar, 2026 | 73,566 | 0 | 0.00% | $568,665.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Mar, 2026 | 49,645 | 5,623 | 12.77% | $383,756.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 41,124 | -11,882 | -22.42% | $317,889.00 |
| UBS Group AG | 31 Mar, 2026 | 38,563 | 30,188 | 360.45% | $298,092.00 |
| Bank of New York Mellon Corp | 31 Mar, 2026 | 30,315 | -1,320 | -4.17% | $234,332.00 |
| MARSHALL WACE, LLP | 31 Mar, 2026 | 29,223 | 29,223 | 0.00% | $225,894.00 |
| CIBC Bancorp USA Inc. | 31 Mar, 2026 | 25,662 | 25,662 | 0.00% | $198,368.00 |
| Morgan Stanley | 31 Mar, 2026 | 22,568 | -5,443 | -19.43% | $174,451.00 |